Serious side effectssuch as signs of pancreatitis, severe abdominal pain, or gallbladder issuesrequire immediate medical attention and should prompt communication with your healthcare team
It is unproven whether BPC-157 causes receptor downregulation in humans
Dual GLP-1/glucagon agonists such as survodutide have demonstrated substantial hepatic fat reduction and MASH improvement, though tolerability optimization may be needed
Here are some simple, everyday meal ideas that can help: Breakfast: Moong dal chilla with paneer filling Moong dal chilla is rich in protein and fibre
# # # Disclosures: Rohit Loomba, MD, is a consultant or advisory board member for Aardvark Therapeutics, Altimmune, Anylam/Regeneron, Amgen, Arrowhead Pharmaceuticals, AstraZeneca, Bristol-Myer Squibb, CohBar, Eli Lilly, Galmed, Gilead, Glympse bio, Hightide, Inipharma, Intercept, Inventiva, Ionis, Janssen Inc., Madrigal, Metacrine, Inc., NGM Biopharmaceuticals, Novartis, Novo Nordisk, Merck, Pfizer, Sagimet, Theratechnologies, 89 bio, Terns Pharmaceuticals and Viking Therapeutics